Wang Jianlei, Ma Delin, Du Gang, An Baokun, Xia Tong, Zhou Tao, Sun Qingmei, Liu Fengyue, Wang Yadong, Sui Deling, Zhai Xiangyu, Jin Bin
Department of Organ Transplantation, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
Front Surg. 2022 Oct 17;9:1003948. doi: 10.3389/fsurg.2022.1003948. eCollection 2022.
Intrahepatic cholangiocarcinoma is a highly malignant and invasive cancer originating from biliary epithelial cells. The current study was designed to evaluate the feasibility, safety, and clinical outcomes of laparoscopic anatomical hepatectomy in patients with intrahepatic cholangiocarcinoma.
After screening, 95 patients who underwent anatomical hepatectomy for intrahepatic cholangiocarcinoma at our center were enrolled and divided into two groups according to the surgical approach; the baseline characteristics, pathological findings, surgical outcomes, and long-term outcomes were compared. Moreover, univariate and multivariate analyses were performed to identify independent prognostic factors for overall survival (OS) and disease-free survival (DFS).
There were no significant differences in baseline characteristics or pathological findings between the two groups. Regarding short-term outcomes, the intraoperative blood loss, incision length, and length of postoperative hospital stay were more favorable in the laparoscopic anatomical hepatectomy group than the open anatomical hepatectomy group ( < 0.05). The two groups differed significantly in the extent of liver resection, with a lower lymph node dissection rate and lymph node yield in the laparoscopic anatomical hepatectomy group ( < 0.05). Furthermore, the postoperative complication rate was similar in the two groups ( > 0.05). The median postoperative follow-up times were 10.7 and 13.8 months in the laparoscopic anatomical hepatectomy and open anatomical hepatectomy groups, respectively. Regarding the long-term follow-up results, OS and DFS were similar in the two groups ( > 0.05). On multivariate analysis, the independent prognostic factors for OS were CA-199, CEA, HGB, tumor diameter, and T stage, and those for DFS were CA-199 ( < 0.05), and T stage ( < 0.05).
laparoscopic anatomical hepatectomy for intrahepatic cholangiocarcinoma is safe and feasible when performed by experienced surgeons. Compared with open anatomical hepatectomy, laparoscopic anatomical hepatectomy provides better short-term outcomes and a comparable long-term prognosis.
肝内胆管癌是一种起源于胆管上皮细胞的高恶性侵袭性癌症。本研究旨在评估腹腔镜解剖性肝切除术治疗肝内胆管癌患者的可行性、安全性及临床疗效。
经筛选,95例行解剖性肝切除术治疗肝内胆管癌的患者纳入本中心研究,并根据手术方式分为两组;比较两组的基线特征、病理结果、手术疗效及长期疗效。此外,进行单因素和多因素分析以确定总生存期(OS)和无病生存期(DFS)的独立预后因素。
两组患者的基线特征和病理结果无显著差异。在短期疗效方面,腹腔镜解剖性肝切除术组的术中出血量、切口长度及术后住院时间均优于开放解剖性肝切除术组(<0.05)。两组肝切除范围差异显著,腹腔镜解剖性肝切除术组的淋巴结清扫率及淋巴结获取量较低(<0.05)。此外,两组术后并发症发生率相似(>0.05)。腹腔镜解剖性肝切除术组和开放解剖性肝切除术组的术后中位随访时间分别为10.7个月和13.8个月。在长期随访结果方面,两组的OS和DFS相似(>0.05)。多因素分析显示,OS的独立预后因素为CA-199、CEA、血红蛋白(HGB)、肿瘤直径及T分期,DFS的独立预后因素为CA-199(<0.05)和T分期(<0.05)。
经验丰富的外科医生实施腹腔镜解剖性肝切除术治疗肝内胆管癌是安全可行的。与开放解剖性肝切除术相比,腹腔镜解剖性肝切除术具有更好的短期疗效和相当的长期预后。